During the past decade, Klinikum Traunstein conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 1 clinical trials were completed, i.e. on average, 11.1% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 1 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Klinikum Traunstein" #1 sponsor was "University of Ulm" with 4 trials, followed by "Deutsches Herzzentrum Muenchen" with 3 trials sponsored, "German High-Grade Non-Hodgkin's Lymphoma Study Group" with 3 trials sponsored, "Stiftung Institut fuer Herzinfarktforschung" with 3 trials sponsored and "AGO Research GmbH" with 3 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Klinikum Traunstein" #1 collaborator was "ClinAssess GmbH" with 2 trials as a collaborator, "Hoffmann-La Roche" with 2 trials as a collaborator, "Technical University of Munich" with 2 trials as a collaborator, "ARCAGY/ GINECO GROUP" with 1 trials as a collaborator and "Arbeitsgemeinschaft Gynaekologische Onkologie Austria" with 1 trials as a collaborator. Other collaborators include 9 different institutions and companies that were collaborators in the rest 19 trials.

According to Clinical.Site data, the most researched conditions in "Klinikum Traunstein" are "Lymphoma" (3 trials), "Acute Myeloid Leukemia" (2 trials), "Acute Myeloid Leukemia (AML)" (2 trials), "Breast Cancer" (2 trials) and "Myocardial Infarction" (2 trials). Many other conditions were trialed in "Klinikum Traunstein" in a lesser frequency.

Most popular intervention types in "Klinikum Traunstein" are "Drug" (19 trials), "Other" (6 trials), "Biological" (4 trials) and "Radiation" (4 trials). Other intervention types were less common.

The name of intervention was led by "Bevacizumab" (3 trials), "Carboplatin" (3 trials), "cyclophosphamide" (3 trials), "doxorubicin hydrochloride" (3 trials) and "prednisone" (3 trials). Other intervention names were less common.

The vast majority of trials in "Klinikum Traunstein" are 22 trials for "All" genders and 5 trials for "Female" genders.

Currently, there are NaN active trials in "Klinikum Traunstein". undefined are not yet recruiting, 5 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 16 completed trials in Klinikum Traunstein, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Klinikum Traunstein, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 0 trials that are defined as “Not Applicable".